Allergan reports mixed results for Q2
IRVINE, Calif. Drug maker Allergan had mixed results during second quarter 2009, according to an earnings release Friday.
The Irvine, Calif.-based company reported diluted earnings per share of 58 cents, compared to 47 cents in second quarter 2008.
At the same time, total product net sales were $1.1 billion, a 3.2% decrease, compared with second quarter 2008 thanks to currency exchange rates, while net sales of specialty pharmaceuticals decreased by 0.6%. Medical device net sales decreased by 14%.